Cargando…
Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes
Retroviral gene therapy offers immense potential to treat many genetic diseases and has already shown efficacy in clinical trials. However, retroviral vector mediated genotoxicity remains a major challenge and clinically relevant approaches to reduce integration near genes and proto-oncogenes are ne...
Autores principales: | Hocum, Jonah D., Linde, Ian, Rae, Dustin T., Collins, Casey P., Matern, Lindsay K., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095648/ https://www.ncbi.nlm.nih.gov/pubmed/27812034 http://dx.doi.org/10.1038/srep36610 |
Ejemplares similares
-
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
por: Everson, Elizabeth M, et al.
Publicado: (2016) -
Evidence for the in vivo safety of insulated foamy viral vectors
por: Browning, Diana L., et al.
Publicado: (2016) -
A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis
por: Rae, Dustin T., et al.
Publicado: (2015) -
Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes
por: Bii, Victor M., et al.
Publicado: (2018) -
Foamy Virus Vectors for HIV Gene Therapy
por: Olszko, Miles E., et al.
Publicado: (2013)